TE VA 7629 (Imatinib Mesylate 100 mg)
Pill with imprint TE VA 7629 is Brown, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
Imatinib is used in the treatment of gastrointestinal stromal tumor; chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TE VA 7629
More about imatinib
- Imatinib Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 36 Reviews
- Drug class: BCR-ABL tyrosine kinase inhibitors
Other brands: Gleevec
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.